RISITANO, ANTONIO MARIA
RISITANO, ANTONIO MARIA
Dipartimento di Medicina clinica e Chirurgia
Molecular Diagnostics in hematology
2009 Maciejewski, Jp; Selleri, C; Risitano, ANTONIO MARIA
Aplastic anemia: immunosuppression. Current challenges and future goals in immunosuppression for aplastic anemia.
2009 Risitano, ANTONIO MARIA
Paroxysmal nocturnal hemoglobinuria
2012 Risitano, ANTONIO MARIA
Immune pathophysiology of aplstic anemia.
2002 Jp, Maciejewski; Risitano, ANTONIO MARIA; H., Kook; W., Zeng; G., Chen; Ns, Y. o. u. n. g.
Multi-center experience using total lymphoid irradiation and anti-thymocyte globulin as conditioning for allografting in hematological malignancies.
2012 Messina, G; Giaccone, L; Festuccia, M; Irrera, G; Scortechini, I; Sorasio, R; Gigli, F; Passera, R; Cavattoni, I; Filippi, Ar; Schianca, Fc; Pini, M; Risitano, ANTONIO MARIA; Selleri, C; Levis, A; Mordini, N; Gallamini, A; Pastano, R; Casini, M; Aglietta, M; Montanari, M; Console, G; Boccadoro, M; Ricardi, U; Bruno, B.
In vivo dominant immune responses in aplastic anemia patients: molecular tracking of putatively pathogenic T cells by TCRb-CDR3 sequencing.
2004 Risitano, ANTONIO MARIA; Maciejewski, Jp; Green, S; Plasilova, M; Zeng, W; Young, N. S.
PEGYLATED-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: SINGLE CENTRE EXPERIENCE
2013 Madonna, Emanuela; Grimaldi, Francesco; Avilia, Simona; Giagnuolo, Giovanna; Marotta, Serena; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro
Molecular Diagnostics in hematology.
2005 Maciejewski, Jp; Selleri, C; Risitano, ANTONIO MARIA
CHRONIC GRAFT Vs HOST DISEASE OF THE GENITAL TRACT: DIAGNOSIS, CLINICAL IMPACT AND MANAGEMENT FROM SURVEILLANCE PROGRAM IN A PRELIMINARY COHORT
2013 Marotta, Serena; Ricciardi, D.; Bertrando, A.; de Rosa, N.; Pagliuca, Simona; Basile, Santina; Cardano, F.; Pane, Fabrizio; DE ROSA, Gennaro; Piccoli, R.; Risitano, ANTONIO MARIA
XM02 PLUS CHEMOTHERAPY IS SAFE AND EFFECTIVE IN STEM CELL MOBILIZATION FOR PATIENTS CANDIDATED TO AUTOLOGOUS STEM CELL TRANSPLANTATION
2013 Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Ricci, P.; Andretta, Claudia; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro
ALEMTUZUMAB FOR APLASTIC ANEMIA AND RELATED IMMUNE-MEDIATED BONE MARROW FAILURES: LONG-TERM FOLLOW UP OF A PILOT STUDY
2011 Risitano, ANTONIO MARIA; Selleri, Carmine; Serio, Bianca; Marando, L.; Marotta, Serena; Raia, M.; De Palma, R.; DEL VECCHIO, Luigi; DE ROSA, Gennaro; Pane, Fabrizio
THIOTEPA AND MELPHALAN AS NEW CONDITIONING REGIMEN FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE LYELOMA
2013 Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro
Significance of oligoclonal and polyclonal expansion within CD8 and CD4 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by VB CDR3 spectratyping and flow cytometry.
2002 Risitano, ANTONIO MARIA; H., Kook; W., Zeng; G., Chen; Ns, Young; Jp, M. a. c. i. e. j. e. w. s. k. i.
Application of the molecular analsysis of the T –cell receptor repertoire in the study of immune-mediated hematologic disease.
2002 Plasilova, M; Risitano, ANTONIO MARIA; Maciejewski, J. P.
Pathological clonal cytotoxic T cell responses - non random nature of the T cell receptor restriction in large granular lymphocytic leukemia.
2005 Wlodarski, Mw; O’Keefe, C; Howe, Ec; Loughran J. r., Tp; Risitano, ANTONIO MARIA; Rodriguez, A; Warshawsky, I; Maciejewski, J. P.
A pilot study of the recombinant soluble human tumor necrosis factor (p75)-Fc fusion protein in patients with myelodysplastic syndrome.
2002 Jp, Maciejewski; Risitano, ANTONIO MARIA; L., Wisch; N., Geller; J., Barrett; Ns, Y. o. u. n. g.
Multicenter phase III study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.
2008 Brodsky, Ra; Young, Ns; Antonioli, E; Risitano, ANTONIO MARIA; Schrezenmeier, H; Schubert, J; Valls, Ag; Coyle, L; de Castro, C; Fu, Cl; Maciejewski, Jp; Bessler, M; Kroon, Ha; Rother, Rp; Hillmen, P.
Preferential suppression of trisomy 8 versus normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodisplastic syndrome.
2005 Sloand, Em; Mainwaring, L; Fuhrer, M; Ramkissoon, S; Risitano, ANTONIO MARIA; Keyvanafar, K; Lu, J; Basu, A; Barrett, Aj; Young, N. S.
Molecular analysis of T cell receptor clonotypes in LGL- A clonal model for polyclonal responses.
2004 O’Keefe, C; Plasilova, M; Risitano, ANTONIO MARIA; Rodriguez, A; Hsi, E; Wlodarski, M; Young, Ns; Maciejewski, J. P.
Fas-mediated apoptosis is important in regulating cell replication and death in trysomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities.
2002 Em, Sloand; S., Kim; M., Fuhrer; Risitano, ANTONIO MARIA; R., Nakamura; J., Maciejewski; J., Barrett; Ns, Y. o. u. n. g.
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
Molecular Diagnostics in hematology | 2.1 Contributo in volume (Capitolo o Saggio) | 2009 | Maciejewski, Jp; Selleri, C; Risitano, ANTONIO MARIA | |
Aplastic anemia: immunosuppression. Current challenges and future goals in immunosuppression for aplastic anemia. | 1.1 Articolo in rivista | 2009 | Risitano, ANTONIO MARIA | |
Paroxysmal nocturnal hemoglobinuria | 2.1 Contributo in volume (Capitolo o Saggio) | 2012 | Risitano, ANTONIO MARIA | |
Immune pathophysiology of aplstic anemia. | 1.1 Articolo in rivista | 2002 | Jp, Maciejewski; Risitano, ANTONIO MARIA; H., Kook; W., Zeng; G., Chen; Ns, Y. o. u. n. g. | |
Multi-center experience using total lymphoid irradiation and anti-thymocyte globulin as conditioning for allografting in hematological malignancies. | 1.1 Articolo in rivista | 2012 | Messina, G; Giaccone, L; Festuccia, M; Irrera, G; Scortechini, I; Sorasio, R; Gigli, F; Passera, R; Cavattoni, I; Filippi, Ar; Schianca, Fc; Pini, M; Risitano, ANTONIO MARIA; Selleri, C; Levis, A; Mordini, N; Gallamini, A; Pastano, R; Casini, M; Aglietta, M; Montanari, M; Console, G; Boccadoro, M; Ricardi, U; Bruno, B. | |
In vivo dominant immune responses in aplastic anemia patients: molecular tracking of putatively pathogenic T cells by TCRb-CDR3 sequencing. | 1.1 Articolo in rivista | 2004 | Risitano, ANTONIO MARIA; Maciejewski, Jp; Green, S; Plasilova, M; Zeng, W; Young, N. S. | |
PEGYLATED-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: SINGLE CENTRE EXPERIENCE | 4.3 Poster | 2013 | Madonna, Emanuela; Grimaldi, Francesco; Avilia, Simona; Giagnuolo, Giovanna; Marotta, Serena; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro | |
Molecular Diagnostics in hematology. | 2.1 Contributo in volume (Capitolo o Saggio) | 2005 | Maciejewski, Jp; Selleri, C; Risitano, ANTONIO MARIA | |
CHRONIC GRAFT Vs HOST DISEASE OF THE GENITAL TRACT: DIAGNOSIS, CLINICAL IMPACT AND MANAGEMENT FROM SURVEILLANCE PROGRAM IN A PRELIMINARY COHORT | 1.1 Articolo in rivista | 2013 | Marotta, Serena; Ricciardi, D.; Bertrando, A.; de Rosa, N.; Pagliuca, Simona; Basile, Santina; Cardano, F.; Pane, Fabrizio; DE ROSA, Gennaro; Piccoli, R.; Risitano, ANTONIO MARIA | |
XM02 PLUS CHEMOTHERAPY IS SAFE AND EFFECTIVE IN STEM CELL MOBILIZATION FOR PATIENTS CANDIDATED TO AUTOLOGOUS STEM CELL TRANSPLANTATION | 4.2 Abstract in Atti di convegno | 2013 | Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Ricci, P.; Andretta, Claudia; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro | |
ALEMTUZUMAB FOR APLASTIC ANEMIA AND RELATED IMMUNE-MEDIATED BONE MARROW FAILURES: LONG-TERM FOLLOW UP OF A PILOT STUDY | 1.5 Abstract in rivista | 2011 | Risitano, ANTONIO MARIA; Selleri, Carmine; Serio, Bianca; Marando, L.; Marotta, Serena; Raia, M.; De Palma, R.; DEL VECCHIO, Luigi; DE ROSA, Gennaro; Pane, Fabrizio | |
THIOTEPA AND MELPHALAN AS NEW CONDITIONING REGIMEN FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE LYELOMA | 1.5 Abstract in rivista | 2013 | Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro | |
Significance of oligoclonal and polyclonal expansion within CD8 and CD4 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by VB CDR3 spectratyping and flow cytometry. | 1.1 Articolo in rivista | 2002 | Risitano, ANTONIO MARIA; H., Kook; W., Zeng; G., Chen; Ns, Young; Jp, M. a. c. i. e. j. e. w. s. k. i. | |
Application of the molecular analsysis of the T –cell receptor repertoire in the study of immune-mediated hematologic disease. | 1.1 Articolo in rivista | 2002 | Plasilova, M; Risitano, ANTONIO MARIA; Maciejewski, J. P. | |
Pathological clonal cytotoxic T cell responses - non random nature of the T cell receptor restriction in large granular lymphocytic leukemia. | 1.1 Articolo in rivista | 2005 | Wlodarski, Mw; O’Keefe, C; Howe, Ec; Loughran J. r., Tp; Risitano, ANTONIO MARIA; Rodriguez, A; Warshawsky, I; Maciejewski, J. P. | |
A pilot study of the recombinant soluble human tumor necrosis factor (p75)-Fc fusion protein in patients with myelodysplastic syndrome. | 1.1 Articolo in rivista | 2002 | Jp, Maciejewski; Risitano, ANTONIO MARIA; L., Wisch; N., Geller; J., Barrett; Ns, Y. o. u. n. g. | |
Multicenter phase III study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. | 1.1 Articolo in rivista | 2008 | Brodsky, Ra; Young, Ns; Antonioli, E; Risitano, ANTONIO MARIA; Schrezenmeier, H; Schubert, J; Valls, Ag; Coyle, L; de Castro, C; Fu, Cl; Maciejewski, Jp; Bessler, M; Kroon, Ha; Rother, Rp; Hillmen, P. | |
Preferential suppression of trisomy 8 versus normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodisplastic syndrome. | 1.1 Articolo in rivista | 2005 | Sloand, Em; Mainwaring, L; Fuhrer, M; Ramkissoon, S; Risitano, ANTONIO MARIA; Keyvanafar, K; Lu, J; Basu, A; Barrett, Aj; Young, N. S. | |
Molecular analysis of T cell receptor clonotypes in LGL- A clonal model for polyclonal responses. | 1.1 Articolo in rivista | 2004 | O’Keefe, C; Plasilova, M; Risitano, ANTONIO MARIA; Rodriguez, A; Hsi, E; Wlodarski, M; Young, Ns; Maciejewski, J. P. | |
Fas-mediated apoptosis is important in regulating cell replication and death in trysomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities. | 1.1 Articolo in rivista | 2002 | Em, Sloand; S., Kim; M., Fuhrer; Risitano, ANTONIO MARIA; R., Nakamura; J., Maciejewski; J., Barrett; Ns, Y. o. u. n. g. |